Samir H Barghout

6PUBLICATIONS
13CO-AUTHORS
Cancer geneticsMolecular targetsCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 21, 2022
Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer.

Francesco Fazzari, Sue Chow, May Cheung

|Sep 09, 2022
Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes.

Samir H Barghout, Mandeep K Mann, Ahmed Aman

|Feb 15, 2022
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer.

Safa Majeed, Mansi K Aparnathi, Kevin C J Nixon

|Nov 12, 2020
E1 Enzymes as Therapeutic Targets in Cancer.

Samir H Barghout, Aaron D Schimmer

|Jun 10, 2018
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.

Samir H Barghout, Parasvi S Patel, Xiaoming Wang

Pageof 1